Oramed Pharmaceuticals Pre-Tax Income 2011-2025 | ORMP

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Oramed Pharmaceuticals pre-tax income from 2011 to 2025. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.

Oramed Pharmaceuticals Pre-Tax Income 2011-2025 | ORMP

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Oramed Pharmaceuticals pre-tax income from 2011 to 2025. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$218.7B
Boston Scientific (BSX)	$152.6B
Stryker (SYK)	$150.8B
EssilorLuxottica (ESLOY)	$131.9B
Medtronic (MDT)	$117.5B
Lonza Group Ag (LZAGY)	$49.6B
Haleon (HLN)	$43.4B
ResMed (RMD)	$39.2B
GE HealthCare Technologies (GEHC)	$35B
Agilent Technologies (A)	$33B
Koninklijke Philips (PHG)	$24.1B
Terumo (TRUMY)	$23.6B
Insulet (PODD)	$20.1B
Zimmer Biomet Holdings (ZBH)	$19.1B
Baxter (BAX)	$14.1B
Smith & Nephew SNATS (SNN)	$13.5B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.7B
Lantheus Holdings (LNTH)	$5B
Perrigo (PRGO)	$3.8B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
ICU Medical (ICUI)	$3.1B
LeMaitre Vascular (LMAT)	$1.8B
QuidelOrtho (QDEL)	$1.7B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.4B